The Efficacy of a Temporary Sub-Placental Uterine Tourniquet in Minimizing Intraoperative Blood L… (NCT05936645) | Clinical Trial Compass
UnknownNot Applicable
The Efficacy of a Temporary Sub-Placental Uterine Tourniquet in Minimizing Intraoperative Blood Loss in Management of Placenta Accreta Spectrum Disorder by a Retrograde Cesarean Hysterectomy (Bladder Last)
Egypt30 participantsStarted 2023-08-01
Plain-language summary
This trial will study the role of a temporary tourniquet around the uterus to reduce blood loss in management of patients with abnormally implanted placenta who will undergo removal of the uterus.
Who can participate
Age range20 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Gestational age: pregnancy completing 35 weeks or more.
* Previous one or more cesarean delivery.
* Current pregnancy complicated by Placenta Accreta Spectrum Disorder candidate for cesarean hysterectomy either total or partial Placenta Accreta. (i.e. Total: Most of the placenta is adherent to the myometrium with no plane of cleavage. Partial: 2-3 cotyledons are only adherent to the myometrium with no plane of cleavage at these cotyledons)
* Elective termination of pregnancy.
* Preoperative Hemoglobin ≥ 10 g/dl
Exclusion Criteria:
* Patients who refuse to participate in the study.
* Women with history of a concomitant chronic or a pregnancy associated medical disorder eg. Gestational diabetes, hypertension, cardiac or renal disease.
* Presence of a concomitant uterine pathology (eg. Uterine fibroid)
* Premature rupture of membranes.
* Cases misdiagnosed as placenta accreta by ultrasound preoperatively, and spontaneous full placental separation occurred intraoperative or as total/partial accreta and found to be focal accreta intraoperative.
* Cases requiring preoperative blood transfusion.